In our annotation, we elaborate on some interesting aspects of the case for both the litigation and M&A practice and discuss our firms experience with the NCC. Read the annotation below or click here (Dutch only).

COVID-19 outbreak and break-up fee

The COVID-19 outbreak has a significant (legal) impact on many businesses and contracts, also in the M&A practice. The fifth judgement of the NCC is one of the first published COVID-19 related commercial cases. For more information on the judgement of 29 April 2020 of the NCC on the enforcement of the break-up fee in COVID-19 circumstances click here. Our firm closely monitors legal developments regarding the COVID-19 outbreak.

NCC

In January 2019, the NCC legislation came into force and the NCC officially opened its doors. The NCC is an international commercial division of the Amsterdam District Court (NCC District Court, including the Court in Preliminary Relief Proceedings) and the Amsterdam Court of Appeal (NCC Court of Appeal) where parties can litigate in English. In short, the NCC aims at efficient, fast and predictable handlings of large, complex cases by expert and specialised judges. With its own rules of procedure, the NCC combines the highly regarded Dutch court system with a flexible focus on global best practices as the NCC rules of procedure are based on the rules of procedure that are used in other commercial courts and arbitration institutions.

The NCC is an exciting and promising new development in the Dutch and international court systems. In practice, parties are increasingly willing to explicitly opt for the NCC and litigate in English (which is required for the NCC to handle a case), not only in transaction documentation but also afterwards (after a dispute occurred).

Contact us

Interested to learn more about the NCC or to bring your dispute before the NCC? Our firm has vast experience with M&A-related litigation and a dedicated team that deals with matters concerning the NCC. For more information, please contact us.

Please read this document for more information.